1 Residual renal function |
15 |
835 |
Std. Mean Difference (IV, Random, 95% CI) |
0.19 [0.05, 0.33] |
1.1 3 months |
3 |
143 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.04 [‐0.37, 0.29] |
1.2 12 months |
6 |
349 |
Std. Mean Difference (IV, Random, 95% CI) |
0.18 [‐0.04, 0.39] |
1.3 24 months |
5 |
218 |
Std. Mean Difference (IV, Random, 95% CI) |
0.33 [0.06, 0.60] |
1.4 3 years + |
1 |
125 |
Std. Mean Difference (IV, Random, 95% CI) |
0.24 [‐0.11, 0.59] |
2 Residual renal function: up to 12 months |
12 |
860 |
Std. Mean Difference (IV, Random, 95% CI) |
0.18 [0.05, 0.32] |
2.1 4 weeks |
1 |
48 |
Std. Mean Difference (IV, Random, 95% CI) |
0.11 [‐0.46, 0.67] |
2.2 3 months |
3 |
143 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.04 [‐0.37, 0.29] |
2.3 6 months |
6 |
440 |
Std. Mean Difference (IV, Random, 95% CI) |
0.32 [0.10, 0.54] |
2.4 8 months |
1 |
91 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.03 [‐0.44, 0.38] |
2.5 9 months |
1 |
138 |
Std. Mean Difference (IV, Random, 95% CI) |
0.21 [‐0.12, 0.55] |
3 Residual renal function: 12 months up to 24 months |
10 |
641 |
Std. Mean Difference (IV, Random, 95% CI) |
0.25 [0.10, 0.41] |
3.1 12 months |
8 |
545 |
Std. Mean Difference (IV, Random, 95% CI) |
0.26 [0.09, 0.43] |
3.2 18 months |
2 |
96 |
Std. Mean Difference (IV, Random, 95% CI) |
0.23 [‐0.17, 0.64] |
4 Residual renal function: 24 months and beyond |
6 |
343 |
Std. Mean Difference (IV, Random, 95% CI) |
0.30 [0.08, 0.51] |
4.1 24 months |
5 |
218 |
Std. Mean Difference (IV, Random, 95% CI) |
0.33 [0.06, 0.60] |
4.2 3 years + |
1 |
125 |
Std. Mean Difference (IV, Random, 95% CI) |
0.24 [‐0.11, 0.59] |
5 Residual renal function: PD fluid types |
15 |
835 |
Std. Mean Difference (IV, Random, 95% CI) |
0.19 [0.05, 0.33] |
5.1 Balance |
9 |
495 |
Std. Mean Difference (IV, Random, 95% CI) |
0.20 [0.02, 0.37] |
5.2 Purely bicarbonate buffered |
3 |
58 |
Std. Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.46, 0.59] |
5.3 Multiple fluid types in treatment group |
2 |
218 |
Std. Mean Difference (IV, Random, 95% CI) |
0.10 [‐0.20, 0.41] |
5.4 Gambrosol trio |
1 |
64 |
Std. Mean Difference (IV, Random, 95% CI) |
0.52 [0.02, 1.02] |
6 Urine volume |
11 |
791 |
Mean Difference (IV, Random, 95% CI) |
114.37 [47.09, 181.65] |
6.1 3 months |
2 |
120 |
Mean Difference (IV, Random, 95% CI) |
‐0.54 [‐515.46, 514.38] |
6.2 12 months |
6 |
392 |
Mean Difference (IV, Random, 95% CI) |
120.94 [45.49, 196.39] |
6.3 24 months |
2 |
154 |
Mean Difference (IV, Random, 95% CI) |
123.27 [‐51.83, 298.36] |
6.4 3 years + |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
270.6 [10.53, 530.67] |
7 Urine volume: up to 12 months |
10 |
819 |
Mean Difference (IV, Random, 95% CI) |
69.72 [‐55.95, 195.40] |
7.1 1 month |
1 |
50 |
Mean Difference (IV, Random, 95% CI) |
‐30.0 [‐399.49, 339.49] |
7.2 3 months |
2 |
120 |
Mean Difference (IV, Random, 95% CI) |
‐0.54 [‐515.46, 514.38] |
7.3 6 months |
6 |
558 |
Mean Difference (IV, Random, 95% CI) |
157.25 [58.48, 256.01] |
7.4 8 months |
1 |
91 |
Mean Difference (IV, Random, 95% CI) |
‐147.2 [‐262.68, ‐31.72] |
8 Urine volume: 12 months up to 24 months |
8 |
579 |
Mean Difference (IV, Random, 95% CI) |
110.57 [40.81, 180.34] |
8.1 12 months |
6 |
392 |
Mean Difference (IV, Random, 95% CI) |
120.94 [45.49, 196.39] |
8.2 18 months |
2 |
187 |
Mean Difference (IV, Random, 95% CI) |
60.94 [‐186.22, 308.10] |
9 Urine volume: 24 months and beyond |
3 |
279 |
Mean Difference (IV, Random, 95% CI) |
169.22 [23.98, 314.46] |
9.1 24 months |
2 |
154 |
Mean Difference (IV, Random, 95% CI) |
123.27 [‐51.83, 298.36] |
9.2 3 years + |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
270.6 [10.53, 530.67] |
10 Urine volume: PD fluid types |
11 |
791 |
Mean Difference (IV, Random, 95% CI) |
114.37 [47.09, 181.65] |
10.1 Balance |
7 |
482 |
Mean Difference (IV, Random, 95% CI) |
120.48 [47.99, 192.97] |
10.2 Purely bicarbonate buffered |
1 |
27 |
Mean Difference (IV, Random, 95% CI) |
345.50 [‐274.17, 965.17] |
10.3 Multiple fluid types in the treatment group |
2 |
218 |
Mean Difference (IV, Random, 95% CI) |
37.84 [‐423.31, 498.99] |
10.4 Gambrosol trio |
1 |
64 |
Mean Difference (IV, Random, 95% CI) |
130.0 [‐105.87, 365.87] |
11 Anuria |
2 |
246 |
Risk Ratio (M‐H, Random, 95% CI) |
0.56 [0.18, 1.75] |
12 Peritoneal ultrafiltration: 4 hours |
9 |
414 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.42 [‐0.74, ‐0.10] |
12.1 2.26%/2.5% glucose |
4 |
218 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.35 [‐0.76, 0.07] |
12.2 3.86%/4.25% glucose |
5 |
196 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.49 [‐1.08, 0.11] |
13 4‐hour dialysate:plasma creatinine (2.27%, 2.4%, or 2.5% glucose) |
10 |
746 |
Mean Difference (IV, Random, 95% CI) |
0.01 [0.00, 0.03] |
13.1 3 months |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.11, 0.09] |
13.2 12 months |
6 |
448 |
Mean Difference (IV, Random, 95% CI) |
0.01 [‐0.01, 0.03] |
13.3 24 months |
2 |
149 |
Mean Difference (IV, Random, 95% CI) |
0.01 [‐0.01, 0.04] |
13.4 3 years + |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
0.06 [0.02, 0.10] |
14 4‐hour dialysis:plasma creatinine (patient characteristics) |
10 |
746 |
Mean Difference (IV, Random, 95% CI) |
0.01 [0.00, 0.03] |
14.1 Incident patients |
7 |
554 |
Mean Difference (IV, Random, 95% CI) |
0.02 [‐0.00, 0.04] |
14.2 Prevalent patients |
3 |
192 |
Mean Difference (IV, Random, 95% CI) |
0.00 [‐0.03, 0.04] |
15 4‐hour dialysis:plasma creatinine (PD fluid types) |
10 |
746 |
Mean Difference (IV, Random, 95% CI) |
0.01 [0.00, 0.03] |
15.1 Balance |
6 |
470 |
Mean Difference (IV, Random, 95% CI) |
0.01 [‐0.01, 0.03] |
15.2 Purely bicarbonate buffered |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.11, 0.09] |
15.3 multiple fluid type in the treatment group |
2 |
187 |
Mean Difference (IV, Random, 95% CI) |
0.03 [‐0.04, 0.10] |
15.4 Gambrosol trio |
1 |
65 |
Mean Difference (IV, Random, 95% CI) |
0.02 [‐0.01, 0.05] |
16 4‐hour dialysis:plasma creatinine (study design) |
10 |
746 |
Mean Difference (IV, Random, 95% CI) |
0.01 [0.00, 0.03] |
16.1 Single centre |
4 |
277 |
Mean Difference (IV, Random, 95% CI) |
0.01 [‐0.01, 0.04] |
16.2 Multicentre |
6 |
469 |
Mean Difference (IV, Random, 95% CI) |
0.02 [‐0.00, 0.04] |
17 Peritoneal creatinine clearance [L/wk/1.73 m²] |
7 |
510 |
Mean Difference (IV, Random, 95% CI) |
‐0.44 [‐2.03, 1.15] |
17.1 3 months |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
‐7.46 [‐20.65, 5.73] |
17.2 12 months |
4 |
273 |
Mean Difference (IV, Random, 95% CI) |
‐0.31 [‐2.28, 1.66] |
17.3 24 months |
1 |
88 |
Mean Difference (IV, Random, 95% CI) |
‐2.60 [‐6.80, 1.60] |
17.4 3 years + |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
1.30 [‐2.37, 4.97] |
18 Peritoneal Kt/V urea |
6 |
422 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.12, 0.09] |
18.1 3 months |
1 |
24 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.78, 0.76] |
18.2 12 months |
4 |
273 |
Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.18, 0.16] |
18.3 3 years + |
1 |
125 |
Mean Difference (IV, Random, 95% CI) |
‐0.04 [‐0.18, 0.10] |
19 Incidence of peritonitis |
12 |
1055 |
Risk Ratio (M‐H, Random, 95% CI) |
1.26 [0.92, 1.72] |
19.1 8 weeks follow‐up |
1 |
59 |
Risk Ratio (M‐H, Random, 95% CI) |
1.58 [0.49, 5.10] |
19.2 24 weeks |
1 |
73 |
Risk Ratio (M‐H, Random, 95% CI) |
1.17 [0.58, 2.36] |
19.3 12 months follow‐up |
5 |
507 |
Risk Ratio (M‐H, Random, 95% CI) |
1.27 [0.93, 1.73] |
19.4 18 months follow‐up |
1 |
69 |
Risk Ratio (M‐H, Random, 95% CI) |
1.07 [0.56, 2.07] |
19.5 24 months follow‐up |
4 |
347 |
Risk Ratio (M‐H, Random, 95% CI) |
1.33 [0.62, 2.84] |
20 Peritonitis rate (episodes/total patient‐months) |
10 |
18184 |
Risk Ratio (M‐H, Random, 95% CI) |
1.18 [0.84, 1.64] |
21 Incidence of peritonitis: attrition bias risk |
12 |
1055 |
Risk Ratio (M‐H, Random, 95% CI) |
1.26 [0.92, 1.72] |
21.1 Low risk |
3 |
359 |
Risk Ratio (M‐H, Random, 95% CI) |
0.65 [0.47, 0.90] |
21.2 High risk |
9 |
696 |
Risk Ratio (M‐H, Random, 95% CI) |
1.58 [1.28, 1.96] |
22 Inflow pain |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
22.1 6 months |
1 |
58 |
Risk Ratio (M‐H, Random, 95% CI) |
0.51 [0.24, 1.08] |
23 Hospitalisation |
2 |
230 |
Mean Difference (IV, Random, 95% CI) |
3.02 [‐7.08, 13.12] |
23.1 12 months |
1 |
48 |
Mean Difference (IV, Random, 95% CI) |
‐0.40 [‐6.71, 5.91] |
23.2 24 months |
1 |
182 |
Mean Difference (IV, Random, 95% CI) |
10.79 [‐4.28, 25.86] |
24 Technique failure (death‐censored) |
15 |
1275 |
Risk Ratio (M‐H, Random, 95% CI) |
1.10 [0.75, 1.63] |
24.1 3 months |
2 |
52 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.2 6 months |
2 |
179 |
Risk Ratio (M‐H, Random, 95% CI) |
0.32 [0.04, 2.97] |
24.3 12 months |
5 |
478 |
Risk Ratio (M‐H, Random, 95% CI) |
0.83 [0.31, 2.21] |
24.4 24 months |
5 |
441 |
Risk Ratio (M‐H, Random, 95% CI) |
1.15 [0.70, 1.90] |
24.5 3 years + |
1 |
125 |
Risk Ratio (M‐H, Random, 95% CI) |
2.89 [0.58, 14.33] |
25 Death (all causes) |
15 |
1229 |
Risk Ratio (M‐H, Random, 95% CI) |
0.73 [0.47, 1.14] |
25.1 3 months |
2 |
52 |
Risk Ratio (M‐H, Random, 95% CI) |
0.16 [0.01, 3.09] |
25.2 12 months follow‐up |
7 |
633 |
Risk Ratio (M‐H, Random, 95% CI) |
0.59 [0.29, 1.19] |
25.3 18 months follow‐up |
1 |
69 |
Risk Ratio (M‐H, Random, 95% CI) |
0.20 [0.02, 1.84] |
25.4 24 months follow‐up |
4 |
350 |
Risk Ratio (M‐H, Random, 95% CI) |
1.18 [0.56, 2.51] |
25.5 3 years + |
1 |
125 |
Risk Ratio (M‐H, Random, 95% CI) |
0.77 [0.29, 2.03] |